[1]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386-389.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
 Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(06):386-389.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
点击复制

小檗碱改善代谢性疾病的肠道相关机制()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
期数:
2014年06期
页码:
386-389
栏目:
综述
出版日期:
2014-12-20

文章信息/Info

Title:
The gut-related mechanisms of berberine in the treatment of metabolic diseases
作者:
姚霜霜张翼飞张志国王卫庆宁光
200025 上海交通大学医学院附属瑞金医院内分泌代谢病科,上海市内分泌代谢病临床医学中心
Author(s):
Yao ShuangshuangZhang YifeiZhang ZhiguoWang WeiqingNing Guang.
Department of Endocrinology and Metabolism,Shanghai Ruijin Hospital Affiliated to Shanghai Jiaotong University,School of Medicine,Shanghai Clinical Center for Endocrine and Metabolism Diseases, Shanghai 200025,China
关键词:
小檗碱 2型糖尿病 肠道激素 肠道菌群
Keywords:
Berberine Type 2 diabetes mellitus Gastrointestinal hormones Gut microbiota
DOI:
10.3760/cma.j.issn.1673-4157.2014.06.007
摘要:
小檗碱是中药黄连的主要成分,临床上常用作抗菌药物,近年来研究发现其有显著的降血糖、改善代谢性疾病相关症状的作用,但机制尚未完全明确。研究显示,小檗碱可通过影响肠道功能发挥作用,其可能机制包括调控肠道激素分泌、调整肠道菌群结构、改善肠道能量代谢、减轻低水平慢性炎性反应、保护肠道屏障功能等。通过探讨小檗碱改善代谢作用的肠道相关机制,可为小檗碱的临床应用提供理论参考,并为代谢性疾病的治疗方法开拓新思路。
Abstract:
Berberine, a major constituent of Chinese herb Coptis Chinensis commonly used as antibacterial agents, has recently been demonstrated to be effective in lowering glucose and alleviating symptoms of metabolic diseases. However, the mechanism has not yet been well explained. Recent researches suggest that the intestinal tract may be associated with its effect. The possible mechanisms include modulating gastrointestinal hormones, adjusting the structure of gut microbiota, improving intestinal metabolism, alleviating low-grade inflammation and protecting intestinal barrier. Further clarifying the intestinal-related mechanisms of berberine’s improvement on metabolism can provide a theoretical basis for its clinical application and develop new ideas for the treatment of metabolic diseases.

参考文献/References:

[1] Xu Y,Wang LM,He J, et al.Prevalence and control of diabetes in Chinese adults[J].JAMA,2013,310(9):948-958.
[2] Xie Q,Johnson BR,Wenckus CS, et al.Efficacy of berberine, an antimicrobial plant alkaloid, as an endodontic irrigant against a mixed-culture biofilm in an in vitro tooth model[J].J Endod,2012,38(8):1114-1117.
[3] Hua W,Ding L,Chen Y, et al.Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry[J].J Pharm Biomed Anal,2007,44(4):931-937.
[4] Ranganath LR.Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1[J].J Clin Pathol,2008,61(4):401-409.
[5] Feng Y,Li Y,Chen C, et al.Inhibiting roles of berberine in gut movement of rodents are related to activation of the endogenous opioid system[J].Phytother Res,2013,27(10):1564-1571.
[6] Yu Y,Liu L,Wang X, et al.Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies[J].Biochem Pharmacol,2010,79(7):1000-1006.
[7] Hellstr?m PM.Glucagon-like peptide-1 gastrointestinal regulatory role in metabolism and motility[J].VitamHorm,2010,84:319-329.
[8] Moran GW,O’neill C,McLaughlin JT.GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier[J].Regulatory Peptides,2012,178(1-3):95-101.
[9] Shan CY,Yang JH,Kong Y, et al.Alteration of the intestinal barrier and GLP2 secretion in Berberine-treated type 2 diabetic rats[J].J Endocrinol,2013,218(3):255-262.
[10] Ley RE,B?ckhed F,Turnbaugh P, et al.Obesity alters gut microbial ecology[J].Proc Natl Acad Sci U S A,2005,102(31):11070-11075.
[11] Turnbaugh PJ,Ley RE,Mahowald MA, et al.An obesity-associated gut microbiome with increased capacity for energy harvest[J].Nature,2006,444(7122):1027-1031.
[12] Larsen N,Vogensen FK,van den Berg FW, et al.Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults[J].PLoS One, 2010, 5(2): e9085.
[13] Xie W,Gu D,Li J, et al.Effects and action mechanisms of berberine and Rhizomacoptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice[J].PLoS One,2011,6(9):e24520.
[14] B?ckhed F,Manchester JK,Semenkovich CF, et al.Mechanisms underlying the resistance to diet-induced obesity in germ-free mice[J].Proc Natl Acad Sci U S A,2007,104(3):979-984.
[15] B?ckhed F,Ding H,Wang T, et al.The gut microbiota as an environmental factor that regulates fat storage[J].Proc Natl Acad Sci U S A,2004,101(44):15718-15723.
[16] 康超颖,张旭,赵梅,等.小檗碱对大鼠肠道菌群结构的体外影响[J].中国微生态学杂志,2013,25(10):1117-1122.
[17] Yadav H,Jain S,Sinha PR.Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats[J].Nutrition,2007,23(1):62-68.
[18] Aronsson L,Huang Y,Parini P, et al.Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein(ANGPTL4)[J].PLoS One,2010,5(9):e13087.
[19] Jeong HW,Hsu KC,Lee JW, et al.Berberine suppresses proinflammatory responses through AMPK activation in macrophages[J].Am J Physiol Endocrinol Metab,2009,296(4):E955-E964.
[20] Zhang X,Zhao Y,Zhang M, et al.Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats[J].PLoS One,2012,7(8):e42529.
[21] Cani PD,Amar J,Iglesias MA, et al.Metabolic endotoxemia initiates obesity and insulin resistance[J].Diabetes,2007,56(7):1761-1772.
[22] Kemp DM.Does chronic low-grade endotoxemia define susceptibility of obese humans to insulin resistance via dietary effects on gut microbiota?[J].Adipocyte,2013,2(3):188-190.
[23] Amyot J,Semache M,Ferdaoussi M, et al.Lipopolysaccharides impair insulin gene expression in isolated islets of Langerhans via Toll-like receptor-4 and NF-κB signalling[J].PLoS One,2012,7(4):e36200.
[24] Li HM,Wang YY,Wang HD, et al.Berberine protects against lipopolysaccharide-induced intestinal injury in mice via alpha 2 adrenoceptor-independent mechanisms[J].Acta Pharmacol Sin,2011,32(11):1364-1372.
[25] Cani PD,Possemiers S,Van de Wiele T, et al.Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability[J].Gut,2009,58(8):1091-1103.
[26] Lee IA,Hyun YJ,Kim DH.Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation[J].Eur J Pharmacol,2010,648(1-3):162-170.
[27] de Moreno de Leblanc A,Dogi CA,Galdeano CM, et al.Effect of the administration of a fermented milk containing Lactobacillus casei DN-114001 on intestinal microbiota and gut associated immune cells of nursing mice and after weaning until immune maturity[J].BMC Immunol,2008,9:27.

相似文献/References:

[1]赵紫琴,雒瑢,田凤石,等.替米沙坦对OLETF大鼠皮下和内脏脂肪组织PPARγ表达的影响[J].国际内分泌代谢杂志,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
 Zhao Ziqin*,Luo Rong,Tian Fengshi,et al.Effects of telmisartan on expression of PPARγ in subcutaneous and visceral adipose tissue in OLETF rats[J].International Journal of Endocrinology and Metabolism,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
[2]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
 Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(06):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[3]刘艳 田秀标 韩颖.GLP-1受体激动剂呈葡萄糖依赖性刺激胰岛β细胞胰岛素分泌的机制[J].国际内分泌代谢杂志,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
 Liu Yan*,Tian Xiubiao,Han Ying..Mechanism of GLP-1 receptor agonists in the stimulation of insulin secretion of islet β cell in a glucose-dependent manner[J].International Journal of Endocrinology and Metabolism,2015,(06):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
[4]刘司漩,刘云峰,尹建红,等.小檗碱对脂多糖诱导的THP-1细胞相关炎性反应因子的影响[J].国际内分泌代谢杂志,2014,(04):233.[doi:10.3760/cma.j.issn.1673-4157.2014.04.005]
 Liu Sixuan*,Liu Yunfeng,Yin Jianhong,et al.Effects of berberine on inflammatory cytokines induced by lipopolysaccharide in THP-1 cells[J].International Journal of Endocrinology and Metabolism,2014,(06):233.[doi:10.3760/cma.j.issn.1673-4157.2014.04.005]
[5]齐利琴,刘礼斌.GLP-1在2型糖尿病诱发的阿尔茨海默病治疗中的作用[J].国际内分泌代谢杂志,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
 Qi Liqin,Liu Libin..Effects of GLP-1 in the treatment of Alzheimer's disease induced by type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(06):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
[6]梅稳,向光大,卢俊颜,等.GDF11对ApoE-/-糖尿病小鼠内皮依赖性 血管舒张功能的作用[J].国际内分泌代谢杂志,2016,36(02):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
 Mei Wen*,Xiang Guangda,Lu Junyan,et al.Effects of GDF11 on endothelium-dependent vasodiation function of aorta in ApoE-/- diabetic mice[J].International Journal of Endocrinology and Metabolism,2016,36(06):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
[7]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白 与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
 Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(06):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[8]王涛,张洁,祁范范,等.不同糖耐量人群血清25(OH)D3水平 及与胰岛β细胞功能的关系[J].国际内分泌代谢杂志,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
 Wang Tao*,Zhang Jie,Qi Fanfan,et al.Relationship between serum 25(OH)D3 level and islet β cell function in individuals with different glucose tolerance[J].International Journal of Endocrinology and Metabolism,2016,36(06):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
[9]陈双双,王楚媛,孔令芳.铬与2型糖尿病[J].国际内分泌代谢杂志,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
 Chen Shuangshuang,Wang Chuyuan,Kong Lingfang.Chromium and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(06):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
[10]涂萍,许婷,段鹏,等.25-羟维生素D3补充对绝经后2型糖尿病 患者胰岛素敏感性及血糖控制的影响[J].国际内分泌代谢杂志,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
 Tu Ping,Xu Ting,Duan Peng,et al.Influence of 25-hydroxyvitamin D3 supplement on insulin sensitivity and glucose control in postmenopausal patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(06):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81170784); 上海市科委医学引导项目(14411964700)
更新日期/Last Update: 2014-12-20